Skip to main content

Table 5 Cox proportional hazards models for recurrence (Stage I)

From: Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

  

Univariate analysis

  

HR (95% CI)

p value

Sex

Male

2.17 (0.85–5.53)

0.1050

Age

≥ 70 years

1.79 (0.75–4.24)

0.1908

Tumor size

> 3 cm

1.41 (0.59–3.35)

0.4413

Stage

≥ IB

1.67 (0.71–3.90)

0.2390

Histology

SCC

1.10 (0.41–2.96)

0.8568

CDK1SA

≥ 12.6

2.57 (1.08–6.09)

0.0335

CDK2SA

≥ 222

1.19 (0.44–3.21)

0.7381